NCT00941239View on ClinicalTrials.gov

Tolerability and Pharmacokinetics of Metformin and Metformin Extended Release (ER)

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Healthy
Interventions
DRUG

metformin ER

850mg daily for 30 days

DRUG

metformin

850 mg daily for 30 days

Trial Locations (1)

64460

Pharmacology and toxicology department, UANL, Monterrey

All Listed Sponsors
lead

Laboratorios Silanes S.A. de C.V.

INDUSTRY

NCT00941239 - Tolerability and Pharmacokinetics of Metformin and Metformin Extended Release (ER) | Biotech Hunter | Biotech Hunter